
“Fat people can’t do pilates”: Ozempic and Fatphobia
2026-03-01
0:00
26:49
Weight loss drugs are changing what’s medically possible, but are they changing what we expect from bodies too? In this episode, we unpack obesity, GLP-1 drugs like Ozempic and Wegovy, and the tension between public health and fatphobia. We discuss whether these medications address a global health crisis, or if they are just reshaping weight stigma with better branding.
Enjoyed the episode? Please leave a like, comment or subscribe :)
Key sources:
- World Health Organization (2024). Obesity and Overweight.
https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight - Ryan et al. (2023). Weight stigma experienced by patients with obesity in healthcare settings: A qualitative evidence synthesis.
https://onlinelibrary.wiley.com/doi/10.1111/obr.13606 - Heitmann (2025). The Impact of Novel Medications for Obesity on Weight Stigma and Societal Attitudes: A Narrative Review.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11799028/
McWhorter, K. L. (2020). Obesity Acceptance: Body Positivity and Clinical Risk Factors. https://www.intechopen.com/chapters/73236
Follow us on our socials so you don’t miss anything!
- Instagram https://www.instagram.com/whi_podcast/
- Tiktok https://www.tiktok.com/@whi_podcast?_t=8cw9TYkj5XG&_r=1
- Twitter https://mobile.twitter.com/whi_podcast
- Facebook https://www.facebook.com/WHIpodcast
- LinkedIn ...
Fler avsnitt från "World Health Investigation Podcast"



Missa inte ett avsnitt av “World Health Investigation Podcast” och prenumerera på det i GetPodcast-appen.








